Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed Conditions

To Determine Bioequivalence Under Fed Conditions Clinical Trial

Official title:
Comparative, Randomized, 3-Way Crossover Bioavailability Study of Par and Bristol-Myers Squibb (Buspar)15 mg Buspirone HCl Tablets Following Administration of a 30 mg Dose in Healthy Adult Males Under Fed and Fasting Conditions

Status Completed

Clinical Trial Summary

To compare the single-dose bioavailability of Par and Bristol-Myers Squibb Buspirone HCl Tablets

Clinical Trial Description

To compare the single-dose bioavailability of Par and Bristol-Myers Squibb (Buspar) 15 mg buspirone HCl tablets, following administration of a 30 mg dose, under fed conditions. In addition, the bioavailability of the Par product was compared under fed and fasting conditions. ;

Study Design

Related Conditions & MeSH terms

Disease
Malnutrition
To Determine Bioequivalence Under Fed Conditions

Clinical Trial Details

NCT number	NCT00652730
Study type	Interventional
Source	Par Pharmaceutical, Inc.
Contact
Status	Completed
Phase	Phase 1
Start date	July 1998
Completion date	September 1998

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00652600` - Bioavailability Study of Propranolol Under Fed Conditions	Phase 1
Completed	`NCT01380496` - Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fed Conditions	Phase 1
Completed	`NCT00652821` - Bioavailability Study of Tramadol/APAP Tablets Under Fed Conditions	Phase 1
Completed	`NCT00652873` - Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed Conditions	Phase 1
Completed	`NCT00652704` - Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions	Phase 1
Completed	`NCT05337969` - The Study Aims to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Assessed.	N/A
Completed	`NCT05329857` - The Study Intends to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Evaluated.	N/A
Completed	`NCT00653003` - Bioavailability Study of Leflunomide Tablets Under Fed Conditions	Phase 1
Completed	`NCT01380431` - A Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study	Phase 1